| Completed | 1 | 27 | | Muti-dose Thalidomide ;Muti-dose Thalidomide and Diclofenac sodium enteric-coated tablets | Chinese PLA General Hospital; Changzhou Pharmaceutical Factory, Changzhou Pharmaceutical Factory | Ankylosing Spondylitis | | | | |
EQUULEUS, NCT01998971: A Study of JNJ-54767414 (HuMax CD38) (Anti-CD38 Monoclonal Antibody) in Combination With Backbone Treatments for the Treatment of Patients With Multiple Myeloma |
|
|
| Completed | 1 | 240 | Europe, US | Daratumumab, Velcade, Pomalidomide, Dexamethasone, Melphalan, Prednisone, Thalidomide, Diphenhydramine, Acetaminophen, Carfilzomib, Lenalidomide, Montelukast | Janssen Research & Development, LLC | Multiple Myeloma | 01/19 | 01/24 | | |
NCT06098014: Safety & Efficacy of Thalidomide in Children With Transfusion Dependent Thalassemia |
|
|
| Completed | 1 | 60 | RoW | Thalidomide Capsules, Placebo | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Transfusion-dependent Thalassemia | 02/24 | 02/24 | | |
NCT01661400: Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid Tumors |
|
|
| Completed | 1 | 14 | US | Metronomic Cyclophosphamide, Cytoxan®, CPM, Thalidomide, Thalomid® | Washington University School of Medicine | Glioma, Neuroectodermal Tumors, Primitive, Wilms Tumor, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Retinoblastoma | 12/23 | 12/23 | | |
ChiCTR2200060742: Effects of thalidomide combined with Camrelizumab on the incidence and efficacy of RCCEP in patients with non-small cell lung cancer |
|
|
| Not yet recruiting | 1 | 100 | | Thalidomide combined with carrilizhu | The Third Affiliated Hospital of Shandong First Medical University; The Third Affiliated Hospital of Shandong First Medical University, self-funded | reactive cutaneous capillary endothelial proliferation | | | | |
